Literature DB >> 24431009

Human pyrroline-5-carboxylate reductase (PYCR1) acts on Δ(1)-piperideine-6-carboxylate generating L-pipecolic acid.

Eduard A Struys1, Erwin E W Jansen, Gajja S Salomons.   

Abstract

We have conducted biochemical studies with commercial available pyrroline-5-carboxylate (P5C) reductase (PYCR1) to investigate whether this enzyme plays a role in L-lysine degradation. Our recent studies with antiquitin/ALDH7A1 deficient fibroblasts revealed an alternative genesis of L-pipecolic acid, and we then hypothesized that PYCR1 was responsible for the conversion of Δ(1)-piperideine-6-carboxylate (P6C) into pipecolic acid. We here present evidence that PYCR1 is indeed able to produce L-pipecolic acid from P6C preparations, and the observed K m for this conversion is of the same magnitude as the K m described for the conversion of P5C to L-proline by PYCR1. Urine samples from antiquitin deficient individuals, who accumulate P6C, were also incubated with PYCR1 which resulted in a marked decrease of P6C and a huge increase of L-pipecolic acid as measured by LC-MS/MS, confirming that indeed PYCR1 generates L-pipecolic acid from P6C.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24431009     DOI: 10.1007/s10545-013-9673-4

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  12 in total

1.  Enantiomeric analysis of D- and L-pipecolic acid in plasma using a chiral capillary gas chromatography column and mass fragmentography.

Authors:  E A Struys; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Alpha-aminoadipic semialdehyde is the biomarker for pyridoxine dependent epilepsy caused by alpha-aminoadipic semialdehyde dehydrogenase deficiency.

Authors:  Eduard A Struys; C Jakobs
Journal:  Mol Genet Metab       Date:  2007-06-08       Impact factor: 4.797

Review 3.  Metabolite damage and its repair or pre-emption.

Authors:  Carole L Linster; Emile Van Schaftingen; Andrew D Hanson
Journal:  Nat Chem Biol       Date:  2013-02       Impact factor: 15.040

4.  Proline inhibition of pyrroline-5-carboxylate reductase: differences in enzymes obtained from animal and tissue culture sources.

Authors:  D Valle; S J Downing; J M Phang
Journal:  Biochem Biophys Res Commun       Date:  1973-10-15       Impact factor: 3.575

5.  Biotransformation of L-lysine to L-pipecolic acid catalyzed by L-lysine 6-aminotransferase and pyrroline-5-carboxylate reductase.

Authors:  Tadashi Fujii; Manabu Mukaihara; Hitosi Agematu; Hiroshi Tsunekawa
Journal:  Biosci Biotechnol Biochem       Date:  2002-03       Impact factor: 2.043

6.  Understanding pyrroline-5-carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine.

Authors:  Diego Martinelli; Johannes Häberle; Vicente Rubio; Cecilia Giunta; Ingrid Hausser; Rosalba Carrozzo; Nadine Gougeard; Clara Marco-Marín; Bianca M Goffredo; Maria Chiara Meschini; Elsa Bevivino; Sara Boenzi; Giovanna Stefania Colafati; Francesco Brancati; Matthias R Baumgartner; Carlo Dionisi-Vici
Journal:  J Inherit Metab Dis       Date:  2011-12-15       Impact factor: 4.982

7.  Pipecolic acid, an endogenous mediator of defense amplification and priming, is a critical regulator of inducible plant immunity.

Authors:  Hana Návarová; Friederike Bernsdorff; Anne-Christin Döring; Jürgen Zeier
Journal:  Plant Cell       Date:  2012-12-07       Impact factor: 11.277

8.  Metabolism of lysine in alpha-aminoadipic semialdehyde dehydrogenase-deficient fibroblasts: evidence for an alternative pathway of pipecolic acid formation.

Authors:  Eduard A Struys; Cornelis Jakobs
Journal:  FEBS Lett       Date:  2010-01-04       Impact factor: 4.124

9.  Mutation in pyrroline-5-carboxylate reductase 1 gene in families with cutis laxa type 2.

Authors:  Duane L Guernsey; Haiyan Jiang; Susan C Evans; Meghan Ferguson; Makoto Matsuoka; Mathew Nightingale; Andrea L Rideout; Sylvie Provost; Karen Bedard; Andrew Orr; Marie-Pierre Dubé; Mark Ludman; Mark E Samuels
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

10.  The measurement of urinary Δ¹-piperideine-6-carboxylate, the alter ego of α-aminoadipic semialdehyde, in Antiquitin deficiency.

Authors:  Eduard A Struys; Levinus A Bok; Dina Emal; Saskia Houterman; Michel A Willemsen; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-01-17       Impact factor: 4.982

View more
  10 in total

1.  Knockdown of PYCR1 inhibits cell proliferation and colony formation via cell cycle arrest and apoptosis in prostate cancer.

Authors:  Tengyue Zeng; Libing Zhu; Min Liao; Wenli Zhuo; Shunliang Yang; Weizhen Wu; Dong Wang
Journal:  Med Oncol       Date:  2017-01-11       Impact factor: 3.064

2.  DHTKD1 and OGDH display substrate overlap in cultured cells and form a hybrid 2-oxo acid dehydrogenase complex in vivo.

Authors:  João Leandro; Tetyana Dodatko; Jan Aten; Natalia S Nemeria; Xu Zhang; Frank Jordan; Ronald C Hendrickson; Roberto Sanchez; Chunli Yu; Robert J DeVita; Sander M Houten
Journal:  Hum Mol Genet       Date:  2020-05-08       Impact factor: 6.150

3.  Understanding cerebral L-lysine metabolism: the role of L-pipecolate metabolism in Gcdh-deficient mice as a model for glutaric aciduria type I.

Authors:  Roland Posset; Silvana Opp; Eduard A Struys; Alfred Völkl; Heribert Mohr; Georg F Hoffmann; Stefan Kölker; Sven W Sauer; Jürgen G Okun
Journal:  J Inherit Metab Dis       Date:  2014-09-12       Impact factor: 4.982

4.  A novel mouse model for pyridoxine-dependent epilepsy due to antiquitin deficiency.

Authors:  Hilal H Al-Shekaili; Terri L Petkau; Izabella Pena; Tess C Lengyell; Nanda M Verhoeven-Duif; Jolita Ciapaite; Marjolein Bosma; Martijn van Faassen; Ido P Kema; Gabriella Horvath; Colin Ross; Elizabeth M Simpson; Jan M Friedman; Clara van Karnebeek; Blair R Leavitt
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

5.  The Proline Cycle As a Potential Cancer Therapy Target.

Authors:  John J Tanner; Sarah-Maria Fendt; Donald F Becker
Journal:  Biochemistry       Date:  2018-04-23       Impact factor: 3.162

Review 6.  Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.

Authors:  Alexandra N Bogner; Kyle M Stiers; John J Tanner
Journal:  Amino Acids       Date:  2021-05-18       Impact factor: 3.520

Review 7.  Reprogramming of mitochondrial proline metabolism promotes liver tumorigenesis.

Authors:  Zhaobing Ding; Russell E Ericksen; Qian Yi Lee; Weiping Han
Journal:  Amino Acids       Date:  2021-02-28       Impact factor: 3.520

8.  PYCR1: A Potential Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma.

Authors:  Huanyu Wang; Weilin Mao; Wenhui Lou; Dayong Jin; Wenchuan Wu; Dansong Wang; Tiantao Kuang; Yefei Rong; Xuefeng Xu; Lei Zhang
Journal:  J Cancer       Date:  2022-02-28       Impact factor: 4.207

Review 9.  Isozymes of P5C reductase (PYCR) in human diseases: focus on cancer.

Authors:  Chien-An A Hu
Journal:  Amino Acids       Date:  2021-07-22       Impact factor: 3.520

Review 10.  The Role of Amino Acids in Neurotransmission and Fluorescent Tools for Their Detection.

Authors:  Rochelin Dalangin; Anna Kim; Robert E Campbell
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.